|
|
||||||||
Departments of 1 Anesthesiology and Pharmacology and of 2 Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota 55905
We recently
reported that expression of recombinant endothelial nitric oxide (NO)
synthase (eNOS) gene in adventitial fibroblasts restores NO formation
in canine cerebral arteries without endothelium in response to
bradykinin ex vivo and in vivo. The present study was designed to
further characterize the stimuli that can activate recombinant eNOS
enzyme expressed in the adventitia of cerebral arteries. To stimulate
recombinant eNOS, we used serum (0.1-10%), substance P
(10
11-3 × 10
9 M), and ANG II
(10
7-10
5
M) because they increase intracellular calcium concentrations in
fibroblasts. Endothelium-denuded segments of canine basilar arteries
were incubated with an adenoviral vector encoding
-galactosidase gene or eNOS gene for 30 min at 37°C. After 24 h, vasomotor
activity and cGMP formation in eNOS or
-galactosidase arteries were
examined by isometric force recording and by radioimmunoassay,
respectively. In control arteries and
-galactosidase gene-transduced
arteries, serum caused concentration-dependent contractions, whereas in recombinant eNOS gene-transduced arteries, serum produced
concentration-dependent relaxations. Substance P and ANG II had no
effect on vascular tone in control and
-galactosidase arteries but
caused concentration-dependent relaxations as well as a significant
increase in cGMP levels in eNOS arteries. These relaxations were
blocked by the NOS inhibitor NG-nitro-L-arginine methyl ester.
Chemical treatment or mechanical inactivation of adventitial function
significantly attenuated substance P-induced relaxations and ANG
II-induced relaxations. These findings demonstrate that
serum, substance P, and ANG II cause adventitia-dependent relaxations
in cerebral arteries expressing the recombinant eNOS gene.
This mechanism of vasodilatation may have beneficial effects in the
prevention and treatment of vascular disorders characterized by the
diminished bioavailability of NO, such as cerebral vasospasm.
angiotensin II; bradykinin; cerebral arteries; gene transfer; nitric oxide; serum; endothelial nitric oxide synthase
This article has been cited by other articles:
![]() |
A.-L. Yang, C. J. Jen, and H.-i. Chen Effects of high-cholesterol diet and parallel exercise training on the vascular function of rabbit aortas: a time course study J Appl Physiol, September 1, 2003; 95(3): 1194 - 1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. J. Schulze-Bauer, P. Regitnig, and G. A. Holzapfel Mechanics of the human femoral adventitia including the high-pressure response Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2427 - H2440. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tsutsui, H. Onoue, Y. Iida, L. Smith, T. O'Brien, and Z. S. Katusic B1 and B2 bradykinin receptors on adventitial fibroblasts of cerebral arteries are coupled to recombinant eNOS Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H367 - H372. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tsutsui, H. Onoue, Y. Iida, L. Smith, T. O'Brien, and Z. S. Katusic Effects of recombinant eNOS gene expression on reactivity of small cerebral arteries Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H420 - H427. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Gutterman Adventitia-dependent influences on vascular function Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1265 - H1272. [Full Text] [PDF] |
||||
![]() |
C. A. J. Schulze-Bauer, P. Regitnig, and G. A. Holzapfel Mechanics of the human femoral adventitia including the high-pressure response Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2427 - H2440. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |